South Korean Eye Surgeons Now Have Greater Choice!
Posted on 19/02/2014
Rayner Intraocular Lenses Limited proudly announced today that registration of the Sulcoflex® Aspheric system pack has been approved by the Korean Food and Drugs Administration, and will now be available for sale in the Republic of Korea. In addition to the C-flex® and Superflex® spherical/aspheric monofocal IOLs, eye surgeons will now be able to offer patients an effective, reversible option for the resolution of post-operative myopic or hypermetropic refractive surprises.
Designed to be implanted into the ciliary sulcus following the implantation of a conventional IOL in the capsular bag, Sulcoflex® was created in response to the growing demand for a lens which would satisfy patients’ high expectations for an excellent refractive result following cataract surgery. Its advanced design ensures supreme ease of use and avoids potential contact with the primary lens.
The Rayner Sulcoflex® Aspheric is another world first for the company, and since being launched in 2007, has been approved and is widely used in over 50 countries.
At the company’s headquarters in Hove, East Sussex, Rayner’s Commercial Director Mark Norris explained, “this exciting news plays an important part in Rayner’s wider growth strategy: expanding the Rayner product range not only in new markets, but in existing markets also. The Sulcoflex lens is a strong performer in our portfolio in other countries and the company is counting on the same success in Korea.”
In addition to the Sulcoflex Aspheric, Rayner’s Sulcoflex® pseudophakic supplementary IOL portfolio also comprises the Sulcoflex Multifocal, SulcoflexToric and Sulcoflex Multifocal Toric. Please contact your local distributor for more details and availability.
-ENDS-
Rayner, the pioneering intraocular lens (IOL) manufacturer has over 60 years of dedication to improving vision and the restoration of sight worldwide. Today, Rayner’s mission remains that of delivering innovative and clinically superior ophthalmic products that consistently respond to the expectations of our global customers and reward the profound trust placed in the Company to improve sight and quality of life.
Headquartered in Hove, East Sussex, United Kingdom, Rayner markets its IOL portfolio and related products worldwide through a network of distributors in over 70 countries and a direct sales team in the United Kingdom, USA, Germany and Austria.
For questions or to schedule an interview with a Rayner representative, please contact Rayner: iol_enquiries@rayner.com
